Hyloris Secures US Approval For Avenacy-Partnered RTU Tranexamic Acid

The ANDA Approval Paves The Way For US Launch In H2 2025

Logo of the US Food and Drug Administration
(Shutterstock)

More from Value Added Medicines

More from Generics Bulletin